Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Treatment of generalized dystonia
Naomi Lubarr
,
Susan Bressman
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of generalized dystonia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Armamentarium
11%
Axial muscles
11%
Baclofen
11%
Childhood-onset
11%
Clinical Benefit
11%
Clinical Improvement
22%
Craniocervical Dystonia
11%
Deep Brain Stimulation
100%
Disease Course
11%
Disease Duration
11%
Dopa-responsive Dystonia
11%
Dystonia
22%
Emotional Costs
11%
Extended Period
11%
First Treatment
11%
Functional Impairment
11%
Generalized Dystonia
100%
High Dose
11%
Levodopa
11%
Limb Dystonia
11%
Limb muscles
11%
Medical Therapy
11%
Medically Refractory
11%
Normal Function
11%
Oral Medication
33%
Patient Selection
11%
Patient's Will
11%
Physical Functioning
11%
Presentation Time
11%
Primary Dystonia
22%
Primary Generalised Dystonia
22%
Secondary Dystonia
11%
Severe Motor Disability
11%
Significant Benefit
11%
Social Functioning
11%
Treatment Options
11%
Trihexyphenidyl
11%
Young Age
11%
Neuroscience
Baclofen
8%
Deep Brain Stimulation
75%
Dystonia
100%
L-DOPA
8%
Stereotypic Movement Disorder
8%
Trihexyphenidyl
8%